clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Podcasts
Learning Labs
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
News & Features
Moderate Calorie Restriction Plus SGLT-2 Achieves Higher Diabetes Remission Rate
News & Features
Polygenic Risk Score Improves COPD Diagnosis
News & Features
Exact Sciences’ MRD Test Impresses in Late-Stage Colon Cancer
News & Features
Largest Genetic Study of Bipolar Disorder Identifies Nearly 300 Risk-Associated Genome…
News & Features
Precision Oncology Treatments Do Not Benefit Patients of All Ancestries Equally
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Podcasts
Learning Labs
Inside Precision Medicine Live
Inside Precision Medicine
AI Improves Prediction of Response to PD-L1 Inhibitors in Urothelial Carcinoma
Urothelial carcinoma
News & Features
AI Improves Prediction of Response to PD-L1 Inhibitors in Urothelial Carcinoma
November 21, 2024
0
News & Features
Sequencing Rates Unacceptably Low in Metastatic Prostate and Urothelial Cancers
Laura Cowen
July 24, 2024
0
News & Features
IDEAYA’s MAT2A Inhibitor Scores in Phase II for Urothelial and NSCLC
July 11, 2024
0
News & Features
First ADC/Immuno-Oncology Combination Approved for Urothelial Cancer
April 4, 2023
0
News & Features
Transcription Factor Specialist Flare Raises $123M and Heads to Clinic
March 22, 2023
0
News & Features
Immunotherapy Reduces Bladder Cancer Recurrence
Alice McCarthy
May 18, 2022
0
News & Features
New Anti-PD-L1 Study Findings Support Immunotherapy for Bladder Cancer
November 13, 2019
0
News & Features
Urothelial Cancer Gets Aid from Precision Medicine
April 5, 2016
0
Related Content
Precision Oncology Treatments Do Not Benefit Patients of All Ancestries Equally
Flatiron and DeepScribe Partner to Bring Ambient AI to the Oncology EMR
Deep Learning Model Shows Promise Detecting Lung Tumors from CT Scans
From Bloodstream to Brain: Accessing the Neurogenetic Medicine Revolution
Inside Precision Medicine
![Drug demonstrates significant activity in patients with platinum-refractory urothelial cancer. [National Cancer Institute]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/602.jpeg "Urothelial Cancer Gets Aid from Precision Medicine")
